ArticleFrontiers in oncology2022

A composite indicator of derived neutrophil-lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors.

Shiyun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.